Zepbound Savings Card: List Price, Coverage, Alternatives

Last reviewed: May 12, 2026 Last updated: May 12, 2026

Written by: Jay Hastings , CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

Looking at the Zepbound savings card and other out-of-pocket options? The PlexusDx Education Hub explains pricing, coverage, and the genetics behind metabolic care. Open the Peptides & GLP-1 library to orient yourself.

Savings programs are a frequent question because Zepbound (tirzepatide) is one of the most-searched GLP-1 medications in the U.S. as of April 2026. This page reports the published list price, the manufacturer savings program, the insurance variables, and the compounded-pharmacy alternatives that exist in this space. Everything here is described as published information, not a guarantee of what any individual will pay.

Set expectations before the specifics. A savings card is only one lever among several, and it interacts with insurance status, the indication on the prescription, and the pharmacy you use. For some people it is the single biggest factor in what they pay; for others, eligibility rules put it out of reach entirely. The sections below place the card alongside list price, coverage, and compounded alternatives so you can see how the pieces fit together rather than treating any one of them as the whole answer.

The published list price

Zepbound list price is approximately $1,059 per month at U.S. list as of April 2026, per Eli Lilly's published pricing. That number is a reference point rather than a typical payment. Out-of-pocket cost varies with insurance coverage, the FDA-approved indication on the prescription, the savings program applied, and the pharmacy where the prescription is filled. List price is rarely what most insured patients actually pay.

Insurance and coverage notes

Coverage depends on whether the prescription is for an FDA-approved indication and on the specific plan formulary. Many commercial plans cover tirzepatide for type 2 diabetes, while coverage for chronic weight management is more variable and is often subject to prior authorization or BMI-based criteria. The practical step is to check directly with your plan as of April 2026, since formularies and rules differ widely.

How the savings card works

Eli Lilly publishes a manufacturer savings card program that can substantially reduce monthly out-of-pocket cost for eligible commercially-insured patients. Independent pharmacy discount platforms such as GoodRx and SingleCare also publish coupon prices that vary by pharmacy. Because eligibility and savings amounts change over time, the reliable move is to verify current terms on the manufacturer website or with your pharmacy at the moment of fill.

Compounded alternatives and the shortage context

Between 2022 and 2024, the FDA listed tirzepatide on its drug shortage list, which opened a regulatory pathway for licensed 503A compounding pharmacies to compound tirzepatide formulations. The FDA resolved the tirzepatide shortage in 2024, narrowing but not eliminating that pathway. Legitimate compounded protocols, when prescribed by a licensed clinician through a state-licensed pharmacy, remain a real option, though pricing and access vary considerably.

PlexusDx protocols and pricing

PlexusDx offers clinician-supervised compounded GLP-1 protocols within its Weight Management Protocols, including Semaglutide Injection, Tirzepatide Injection, oral formulations, a Microdose GLP-1 option, and GLP-Squared. Current pricing appears on each product page as of April 2026, and the relevant page is the accurate source rather than any third-party quote.

The broader takeaway is that no single program tells the whole story. What you ultimately pay reflects how your insurance status, the indication on your prescription, any savings program, and the pharmacy you choose all stack together. Treating those as one connected system, rather than as isolated coupons, is what makes an out-of-pocket estimate realistic.

The genetic context before you spend

Upstream of any pricing decision, your metabolic baseline matters. Variants in FTO, MC4R, and GLP1R influence appetite, satiety, and receptor biology as pathway-level traits, not predictions of medication response. The PlexusDx Precision Peptide Genetic Test analyzes 14 pathways, 49 peptides, 150+ genetic insights so that context is available before you commit, as education rather than a genetic forecast.

Frequently Asked Questions

How much is Zepbound without insurance?

List price is approximately $1,059 per month at U.S. list as of April 2026, per Eli Lilly's published pricing. Without insurance and without a savings card, that list price is what cash-pay patients face at most U.S. pharmacies. Compounded alternatives, manufacturer programs, and pharmacy discount cards can substantially reduce out-of-pocket cost.

Is there a savings card for Zepbound?

Yes. Eli Lilly publishes a manufacturer savings card that can substantially reduce monthly out-of-pocket cost for eligible commercially-insured patients. Independent pharmacy coupons such as GoodRx and SingleCare also publish discounted prices that vary by pharmacy and change frequently. Verify eligibility and terms at the time of fill.

Why is the list price so high?

Zepbound is a patent-protected branded medication, and Eli Lilly sets list price based on research cost recovery, market positioning, and expected payer mix. Prices have stayed high in part because demand outpaced manufacturing across 2023 and 2024. Compounded alternatives and savings programs are the main levers patients use to lower cost.

Are compounded versions cheaper?

Often yes. Compounded tirzepatide from licensed 503A pharmacies has historically been priced well below Zepbound list price. The trade-offs include regulatory complexity, variability in prescriber oversight, and the FDA's evolving stance on compounding after the 2024 shortage resolution. Discuss suitability with a qualified clinician.

For more on pricing, coverage, and the genetics behind metabolic care, return to the PlexusDx Education Hub.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.